1.39BMarket Cap98.15P/E (TTM)
20.125High19.560Low72.77KVolume20.060Open19.990Pre Close1.44MTurnover0.23%Turnover Ratio98.15P/E (Static)70.62MShares22.09052wk High3.16P/B620.92MFloat Cap10.29052wk Low--Dividend TTM31.63MShs Float32.880Historical High--Div YieldTTM2.83%Amplitude5.010Historical Low19.759Avg Price1Lot Size
Kiniksa Pharmaceuticals Stock Forum
Upcoming Ph 2 readouts in Q1 2024…
$Regenxbio(RGNX.US)$ Phase 2
$Leap Therapeutics(LPTX.US)$ Phase 2
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals(EYPT.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US)$ Phase 2
$Disc Medicine(IRON.US)$ Phase 2
$Atea Pharmaceuticals(AVIR.US)$ Phase 2
$Allakos(ALLK.US)$ Phase 2...
Market analysis- 09Oct2022
i) Current market- $SPDR S&P 500 ETF(SPY.US)$
ii) Oil price
iii) My trade based on stage analysis
i) To be honest, after the last month CPI showed that the inflation is still not under controlled, the big sell off volume ha...
No comment yet